The Follicle Stimulating Hormone Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
In the Follicle Stimulating Hormone Global Market Report 2024 market, the market size has been increasing significantly. It is projected to rise from $2.03 billion in 2024 to $2.14 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%.
The global market for follicle stimulating hormone is projected to reach $2.64 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.4%.
Download Your Free Sample of the 2025 Follicle Stimulating Hormone Market Report and Uncover Key Trends Now!The key drivers in the follicle stimulating hormone market are:
• Widening therapeutic applications of follicle stimulating hormones
• Rising demand for combination therapy in treatments
• Increasing requirement for effective contraceptive options
• Market expansion in key geographical regions
The follicle stimulating hormone market covered in this report is segmented –
1) By Type: Recombinant FSH, Urinary FSH
2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) By End-Users: Infertility Center, Hospitals, Other End-Users
The key trends in the follicle stimulating hormone market are:
• The emergence of advanced biosimilar FSH products is a key trend shaping the market.
• Regulatory approvals and market access are increasingly influencing the future of the market.
• Technological advancements in FSH production and delivery are becoming more pivotal.
• The need for effective contraceptive options is a growing trend shaping the market.
The major players in the follicle stimulating hormone market are:
• Pfizer Inc
North America was the largest region in the follicle stimulating hormone market in 2024